Metformin in Australia: A Doctor’s Practical Review

Written for Australians over 30 who want to take control of their blood sugar and long-term health.

Attention: The Silent Danger of High Blood Sugar

If you are over 30, there is a good chance you know someone with type 2 diabetes—or you have been told your own blood sugar is “not quite right.” Australia is facing a diabetes epidemic: more than 1.3 million people are living with diabetes, and many more have prediabetes without knowing it. High blood sugar can quietly damage your heart, kidneys, eyes, nerves and blood vessels. The fear is real: needles, dialysis, heart attack, stroke, blindness, amputation, and medications that cost too much or cause weight gain.

Here is the good news: one of the most powerful, safest and most affordable tools in Australian medicine has been available for decades. It is called metformin, and as a doctor I still consider it the foundation of type 2 diabetes care.

Interest: Why Australian Doctors Reach for Metformin First

Metformin is not a new or expensive drug. It is a PBS-listed tablet that lowers blood glucose by reducing the liver’s excess glucose production and helping your body respond better to its own insulin. It does not stimulate insulin release, so when used alone it does not cause dangerous hypos. It is weight neutral—many people even lose a small amount of weight. It is taken by mouth, not injection.

Like all medicines, metformin can cause stomach upset, diarrhoea or nausea. Starting with a low dose, taking it with food, and using the extended-release form can help. Lactic acidosis is extremely rare and mainly occurs in people with severe kidney or liver disease. Your GP will check your kidney function before and during treatment.

How Does Metformin Fit into the Australian Health System?

In Australia, metformin is recommended as the first-line glucose-lowering medicine for type 2 diabetes in national guidelines, including those from the Royal Australian College of General Practitioners (RACGP) and the Australian Diabetes Society. It is on the Pharmaceutical Benefits Scheme (PBS), which means most Australians pay a modest co-payment rather than the full private price. It is widely available in 500 mg, 850 mg and 1000 mg immediate-release tablets, as well as extended-release forms.

For doctors, metformin is the default starting point after lifestyle changes. It fits perfectly into a GP-led chronic disease management plan, team care arrangement, and home medicines review. Because it is affordable and well tolerated, it helps patients stay on treatment long term—one of the biggest challenges in diabetes care.

How to Apply for PBS Authority for Metformin

One common question is whether metformin needs an authority prescription. For most standard immediate-release metformin prescriptions, no PBS authority is required—it is a general schedule item. Some extended-release brands or higher quantities may trigger a streamlined authority prompt in the prescribing software. The process is simple and usually electronic.

If you have prediabetes, metformin is not PBS-subsidised for that indication in Australia. Your GP may still prescribe it privately, but you will pay the private price. This is an important distinction to discuss.

Metformin and Cardiovascular Outcomes Trials in Diabetes

Why do doctors trust metformin so much? The landmark UK Prospective Diabetes Study (UKPDS) showed that in newly diagnosed overweight people with type 2 diabetes, metformin reduced the risk of heart attack and death from any cause compared with other treatments. After decades of follow-up, the benefits persisted—a phenomenon called the “legacy effect.”

Modern cardiovascular outcome trials also use metformin as the background therapy, confirming its central role. While newer drugs such as empagliflozin and GLP-1 receptor agonists have proven heart and kidney benefits, they are almost always added to metformin—not used instead of it.

When Is It Appropriate to Add a Second Agent to Metformin?

Metformin is excellent, but diabetes can progress. Australian guidelines suggest reviewing HbA1c 3–6 months after starting metformin. If the target—usually an HbA1c of 7% or less, individualised—is not reached, it is time to consider a second agent. This does not mean metformin has failed; it means your body needs extra help.

Can Metformin Prevent Macrosomia?

Many women over 30 worry about having a large baby (macrosomia), especially if they have gestational diabetes, polycystic ovary syndrome (PCOS) or insulin resistance. Macrosomia can lead to difficult births, caesarean section, shoulder dystocia and neonatal low blood sugar.

Metformin crosses the placenta, so it is not automatically first choice in pregnancy. However, in gestational diabetes, the MiG trial and follow-up studies found that metformin compared with insulin produced similar pregnancy outcomes, with less maternal weight gain and fewer severe neonatal hypoglycaemic episodes. Some Australian obstetricians and endocrinologists use metformin in gestational diabetes when insulin is not acceptable or practical. It may help reduce excessive fetal growth in some women, but it is not a guarantee. Always discuss with your obstetric team.

Can Metformin Be Used for Prediabetes in Australia?

Prediabetes means your blood sugar is higher than normal but not yet in the diabetes range. In Australia, it is usually defined by an HbA1c of 6.0%–6.4% or impaired fasting glucose/impaired glucose tolerance. Lifestyle change—losing 5–10% of body weight and increasing activity—is the most powerful intervention and can reduce progression to diabetes by nearly 60%.

Metformin can also reduce progression from prediabetes to type 2 diabetes by about 31% in large studies. In Australia, metformin is not PBS-subsidised for prediabetes, but some GPs and endocrinologists prescribe it privately for high-risk people, especially those with obesity, a strong family history, previous gestational diabetes or rapidly rising HbA1c. If you have prediabetes, ask your GP whether metformin is appropriate for you.

Metformin and Empagliflozin Combination

One of the most powerful modern combinations in type 2 diabetes is metformin plus empagliflozin (an SGLT2 inhibitor). They work in complementary ways: metformin reduces liver glucose output, while empagliflozin makes the kidneys excrete excess glucose in urine.

In Australia, this combination is available as separate PBS-listed medicines and as a fixed-dose combination tablet (metformin/empagliflozin). Your GP may recommend it if you have heart disease, heart failure, kidney disease, or need better glucose control without weight gain.

Metformin and Pioglitazone Combination

Another effective oral combination is metformin plus pioglitazone. Pioglitazone improves insulin sensitivity in fat and muscle, while metformin reduces liver glucose production. Together they tackle two core defects of type 2 diabetes without causing hypoglycaemia.

Because of fluid retention, pioglitazone is not suitable for people with heart failure. It is usually PBS-subsidised after metformin, with an authority prescription.

Desire: Imagine Life with Better Control

Imagine taking a tablet that costs little, does not cause hypos, does not pile on weight, and has decades of evidence that it protects your heart. Imagine avoiding or delaying insulin injections, reducing your risk of heart attack and dialysis, and working with your GP to build a plan that fits your life. That is what metformin offers. It is not a miracle, but it is the closest thing to a foundation stone in type 2 diabetes care.

Action: Talk to Your Doctor Today

If you are over 30 and have type 2 diabetes, prediabetes, PCOS, or a family history of diabetes, start the conversation. Ask your GP: “Is metformin right for me?” Bring your latest blood test results, discuss your HbA1c target, and ask about PBS access, side effects and combination options. A single appointment could change the next 20 years of your health.

This article is general information and not individual medical advice. Always consult your GP or endocrinologist before starting or changing any medication.